BSECompany Update8h ago · 11 Nov 2026, 12:53 pm
Corrigendum to the Press Release-Interview published in the Times of India dated November 11,2026 regarding Financial Performance for the Quarter and Half Year ended September 30, 2026
Suraksha Diagnostic Ltd · 544293
✦ AI SummaryResults
Suraksha Diagnostic Ltd issued a corrigendum to correct errors in a press release regarding its financial performance for Q2 FY 2026-27. The corrections include changing the headline to 'Suraksha Diag sees over 100 Crore total income in Q2' and correcting the quarter-on-quarter net profit to ₹15 Crore.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suraksha Diagnostic Ltd - 544293 - Corrigendum To The Press Release -Interview Published In The Times Of India Dated November 11, 2026, Regarding Financial Performance For The Quarter And Half Year Ended September 30, 2026.
Attachments (1)
📄pdf
Download →
514e3c00-0e64-4c3f-9e3a-329faf881e6a.pdf
View document text
Date: November 11, 2026
The Secretary The Secretary
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block
Dalal Street Bandra - Kurla Complex, Bandra (East)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 544293 Scrip Symbol: SURAKSHA
Dear Sir / Ma’am,
Sub: Corrigendum to the Press Release -Interview published in The Times of India dated November
11, 2026, regarding Financial Performance for the Quarter and Half Year ended September 30, 2026.
With reference to the Press Release - Interview published in The Times of India dated November 11, 2026,
concerning the financial performance of the Company for the quarter and half year ended September
30, 2026, we wish to inform you that certain inadvertent errors have occurred in the said publication.
Accordingly, the following corrected heading should read:
A. The headline “Suraksha Diag sees over 100 Crore net profit in Q2” shall be corrected and read
as “Suraksha Diag sees over 100 Crore total income in Q2”.
B. Under the heading “Highlights Q2 FY 2026-27, the Quarter-on-Quarter Net Profit has been
inadvertently mentioned as ₹100.5 Crore”. Accordingly, the same shall be read as “Quarter-on-
Quarter Net Profit stood at ₹15 Crore for Q2 FY 2026-27”.
The aforesaid corrections are being issued to clarify the actual financial performance of the Company
and rectify the inadvertent errors in the publication.
You are requested to kindly take the above corrigendum for your record.
For Suraksha Diagnostic Limited
Shreya Arora
Company Secretary & Compliance Officer
Membership No.: 30892
Suraksha Diagnostic Limited
(Formerly known as Suraksha Diagnostic Private Limited)
CIN: L85110WB2005PLC102265
Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New
Town, Kolkata-700 156, West Bengal, India
E-mail: investors@surakshanet.com I Website: www.surakshanet.com
Phone:(033) 6605 9750